INO-4201 as Booster in Healthy VSV-ZEBOV Vaccinees
NCT04906629
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
46
Enrollment
OTHER
Sponsor class
Conditions
Ebola Virus Disease
Interventions
BIOLOGICAL:
INO-4201
BIOLOGICAL:
Placebo
Sponsor
University of Geneva, Switzerland
Collaborators
[object Object]
[object Object]
[object Object]